We provide you with 20 years of free, institutional-grade data for MGTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGTX. Explore the full financial landscape of MGTX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | Initial | 2023-09-18 | |||
| Indyk Martin | Derivatives Exercise | 15,000 | 2023-06-09 | ||
| Harris Keith R. | Derivatives Exercise | 20,000 | 2023-06-09 | ||
| PERCEPTIVE ADVISORS LLC | Open Market Purchase | 4,347,826 | $5.75 | 2023-05-15 | |
| Zeldin Robert K | Sale | -29,513 | $6.99 | $206,296 | 2023-01-18 |
| Zeldin Robert K | Derivatives Exercise | 75,000 | 2023-01-18 | ||
| Wollin Robert J | Sale | -5,288 | $6.99 | $36,963 | 2023-01-18 |
| Wollin Robert J | Derivatives Exercise | 10,000 | 2023-01-18 | ||
| Giroux Richard | Sale | -26,438 | $6.99 | $184,802 | 2023-01-18 |
| Giroux Richard | Derivatives Exercise | 50,000 | 2023-01-18 | ||
| Naylor Stuart | Sale | -22,325 | $6.99 | $156,052 | 2023-01-18 |
| Naylor Stuart | Derivatives Exercise | 47,500 | 2023-01-18 | ||
| Forbes Alexandria | Sale | -31,726 | $6.99 | $221,765 | 2023-01-18 |
| Forbes Alexandria | Derivatives Exercise | 60,000 | 2023-01-18 | ||
| Naylor Stuart | Sale | -18,800 | $6.6 | $124,080 | 2023-01-10 |
| Naylor Stuart | Derivatives Exercise | 40,000 | 2023-01-10 | ||
| Giroux Richard | Sale | -19,829 | $6.6 | $130,871 | 2023-01-10 |
| Giroux Richard | Derivatives Exercise | 37,500 | 2023-01-10 | ||
| Forbes Alexandria | Sale | -25,777 | $6.6 | $170,128 | 2023-01-10 |
| Forbes Alexandria | Derivatives Exercise | 48,750 | 2023-01-10 | ||
| Zeldin Robert K | Open Market Purchase | 5,000 | $7.9 | 2022-06-06 | |
| Wollin Robert J | Open Market Purchase | 1,000 | $7.94 | 2022-05-26 | |
| Forbes Alexandria | Sale | -51,554 | $21.53 | $1,109,958 | 2022-01-11 |
| Forbes Alexandria | Derivatives Exercise | 97,500 | 2022-01-11 | ||
| Giroux Richard | Sale | -39,657 | $21.53 | $853,815 | 2022-01-11 |
| Giroux Richard | Derivatives Exercise | 75,000 | 2022-01-11 | ||
| Naylor Stuart | Sale | -37,600 | $21.53 | $809,528 | 2022-01-11 |
| Naylor Stuart | Derivatives Exercise | 80,000 | 2022-01-11 | ||
| Forbes Alexandria | Sale | -30,000 | $19.82 | $594,600 | 2021-11-18 |
| Giroux Richard | Sale | -22,000 | $20.07 | $441,540 | 2021-10-21 |
| Naylor Stuart | Sale | -12,000 | $17.95 | $215,400 | 2021-10-20 |
| Forbes Alexandria | Sale | -30,000 | $17.21 | $516,300 | 2021-10-20 |
| Naylor Stuart | Sale | -9,390 | $15.06 | $141,413 | 2021-07-21 |
| Naylor Stuart | Sale | -2,610 | $15.04 | $39,254 | 2021-07-15 |
| Forbes Alexandria | Sale | -30,000 | $15.03 | $450,900 | 2021-06-09 |
| Naylor Stuart | Sale | -6,082 | $15.02 | $91,352 | 2021-06-09 |
| Naylor Stuart | Sale | -10,354 | $15.14 | $156,760 | 2021-04-30 |
| MARCUS JOEL S | Derivatives Exercise | 12,882 | 2021-03-17 | ||
| Forbes Alexandria | Sale | -30,000 | $15.6 | $468,000 | 2021-02-18 |
| Naylor Stuart | Sale | -16,851 | $15 | $252,765 | 2021-01-06 |
| Forbes Alexandria | Sale | -13,390 | $15 | $200,850 | 2020-12-21 |
| Giroux Richard | Sale | -18,000 | $16 | $288,000 | 2020-12-21 |
| PERCEPTIVE ADVISORS LLC | Open Market Purchase | 500,000 | $12.85 | 2020-11-24 | |
| Forbes Alexandria | Sale | -42,629 | $15.05 | $641,566 | 2020-11-19 |
| Forbes Alexandria | Sale | -23,052 | $15.05 | $346,933 | 2020-11-12 |
| Naylor Stuart | Sale | -3,739 | $15 | $56,085 | 2020-11-12 |
| Naylor Stuart | Sale | -8,794 | $15.02 | $132,086 | 2020-11-09 |
| Forbes Alexandria | Sale | -3,981 | $15.03 | $59,834 | 2020-11-09 |
| Naylor Stuart | Sale | -301 | $15 | $4,515 | 2020-10-07 |
| MARCUS JOEL S | Sale | -15,459 | $13.86 | $214,262 | 2020-08-12 |
| MARCUS JOEL S | Derivatives Exercise | 15,459 | 2020-08-12 | ||
| SHENK THOMAS E | Sale | -6,667 | $15 | $100,005 | 2020-07-22 |
| Naylor Stuart | Sale | -10,054 | $15 | $150,810 | 2020-07-22 |
| Giroux Richard | Sale | -17,929 | $15.03 | $269,473 | 2020-05-22 |
| Forbes Alexandria | Sale | -30,000 | $15.04 | $451,200 | 2020-05-22 |
| Giroux Richard | Sale | -71 | $15.38 | $1,092 | 2020-05-15 |
| MARCUS JOEL S | Sale | -4,922 | $15.77 | $77,620 | 2020-05-14 |
| SHENK THOMAS E | Sale | -2,184 | $15 | $32,760 | 2020-05-13 |
| Naylor Stuart | Sale | -11,304 | $15.39 | $173,969 | 2020-05-13 |
| Naylor Stuart | Sale | -696 | $15 | $10,440 | 2020-04-22 |
| SHENK THOMAS E | Sale | -4,482 | $15 | $67,230 | 2020-04-22 |
The information provided in this report about MGTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
MeiraGTx Holdings plc(NASDAQ:MGTX) 
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck ...
Website: http://www.meiragtx.com
Founded: 2015
Full Time Employees: 206
Sector: Healthcare
Industry: Biotechnology